ampicillin has been researched along with virginiamycin in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (21.05) | 18.7374 |
1990's | 9 (47.37) | 18.2507 |
2000's | 5 (26.32) | 29.6817 |
2010's | 1 (5.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inoue, K; Inoue, M; Mitsuhashi, S; Okamoto, R; Okubo, T | 1 |
Barnum, DA; Hariharan, H | 1 |
Legler, F | 1 |
Hohenegger, M; Hromadka, A | 1 |
Gaines, SA; Rollins, LD; Selwyn, M; Williams, RD | 1 |
Herrera-Insúa, I; Jacques-Palaz, K; Murray, BE; Rakita, RM | 1 |
Chow, JW; Davidson, A; Sanford, E; Zervos, MJ | 1 |
Deobaldia, J; Evans, PA; Norden, CW; Rhoads, S; Silber, JL | 1 |
Messick, CR; Pendland, SL | 1 |
Jorgensen, JH; McElmeel, ML | 1 |
Messick, CR; Pendland, SL; Woodward, J | 1 |
Aeschlimann, JR; Hershberger, E; Moldovan, T; Rybak, MJ | 1 |
Messick, CR; Pendland, SL; Rodvold, KA | 1 |
Fujita, N | 1 |
Ahrén, IL; Forsgren, A; Karlsson, E; Riesbeck, K | 1 |
Lavin, B; Talbot, GH; Thompson, RL | 1 |
Bethea, JA; Targos, PA; Walko, CM | 1 |
Heo, ST; Ki, HK; Kiem, S; Ko, KS; Lee, JY; Moon, CS; Oh, WS; Peck, KR; Song, JH | 1 |
Hao, Y; Mao, R; Teng, D; Wang, J; Wang, X; Yang, N; Zong, L | 1 |
1 review(s) available for ampicillin and virginiamycin
Article | Year |
---|---|
[Vancomycin-resistant enterococci (VRE)].
Topics: Ampicillin; Animals; Bacteremia; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Enterococcus; Gentamicins; Humans; Immunocompromised Host; Risk Factors; Urinary Tract Infections; Vancomycin Resistance; Virginiamycin | 2000 |
18 other study(ies) available for ampicillin and virginiamycin
Article | Year |
---|---|
Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.
Topics: Ampicillin; Cefotaxime; Erythromycin; Gram-Positive Cocci; Humans; In Vitro Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Virginiamycin | 1992 |
Minimal inhibitory concentrations of twenty antimicrobial agents to animal pathogens.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Cephaloridine; Chloramphenicol; Cloxacillin; Erythromycin; Escherichia coli; Framycetin; Gentamicins; Kanamycin; Leucomycins; Lincomycin; Methicillin; Microbial Sensitivity Tests; Nalidixic Acid; Novobiocin; Oleandomycin; Penicillin Resistance; Penicillins; Polymyxins; Pseudomonas aeruginosa; Salmonella typhimurium; Spectinomycin; Staphylococcus; Virginiamycin | 1974 |
[Present resistance status of Staphylococcus aureus under specific consideration of the antibiotics virgimycia, cephalothin and fusidic acid].
Topics: Adult; Ampicillin; Animals; Anti-Bacterial Agents; Bacitracin; Cephalothin; Child; Chloramphenicol; Erythromycin; Fusidic Acid; Humans; Neomycin; Nitrofurantoin; Oleandomycin; Penicillin G; Penicillin Resistance; Penicillin V; Staphylococcus; Streptomycin; Sulfonamides; Tetracycline; Virginiamycin | 1967 |
[Sensitivity of staphylococci to antibiotics].
Topics: Ampicillin; Anti-Bacterial Agents; Cephalothin; Chloramphenicol; Chlortetracycline; Culture Media; Erythromycin; Kanamycin; Methicillin; Oxytetracycline; Penicillin G; Penicillin Resistance; Rifampin; Staphylococcus; Streptomycin; Vancomycin; Virginiamycin | 1966 |
Effect of penicillin and virginiamycin on drug resistance in lactose-fermenting enteric flora.
Topics: Ampicillin; Animal Feed; Animals; Bacteria; Dihydrostreptomycin Sulfate; Dogs; Female; Fermentation; Food Additives; Intestines; Lactose; Male; Penicillin Resistance; Penicillins; Tetracycline; Virginiamycin | 1980 |
Intracellular activities of RP 59500 (quinupristin-dalfopristin) and sparfloxacin against Enterococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus faecium; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neutrophils; Quinolones; Vancomycin; Virginiamycin | 1996 |
Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Coronary Artery Bypass; Diabetes Mellitus, Type 1; Drug Hypersensitivity; Endocarditis; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus; Superinfection; Vancomycin; Virginiamycin; Wound Infection | 1997 |
In vitro susceptibilities of clinical isolates of vancomycin-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin | 1997 |
In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin | 1997 |
Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae.
Topics: Ampicillin; Anti-Bacterial Agents; Culture Media; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Penicillins; Virginiamycin | 1997 |
In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1998 |
Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by
Topics: Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Glycopeptides; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Rifampin; Staphylococcus aureus; Sulbactam; Teicoplanin; Time Factors; Vancomycin; Virginiamycin | 1999 |
Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinations.
Topics: Ampicillin; Chloramphenicol; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Kinetics; Microbial Sensitivity Tests; Time Factors; Vancomycin; Virginiamycin | 1999 |
Comparison of the antibacterial activities of ampicillin, ciprofloxacin, clarithromycin, telithromycin and quinupristin/dalfopristin against intracellular non-typeable Haemophilus influenzae.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Typing Techniques; Ciprofloxacin; Clarithromycin; Haemophilus influenzae; Humans; Intracellular Fluid; Ketolides; Macrolides; Microbial Sensitivity Tests; Tumor Cells, Cultured; Virginiamycin | 2002 |
Endocarditis due to vancomycin-resistant Enterococcus faecium in an immunocompromised patient: cure by administering combination therapy with quinupristin/dalfopristin and high-dose ampicillin.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Diabetes Mellitus, Type 1; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Kidney Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Recurrence; Treatment Outcome; Vancomycin Resistance; Virginiamycin | 2003 |
Treatment of vancomycin-resistant enterococcus with quinupristin/dalfopristin and high-dose ampicillin.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Drug Therapy, Combination; Enterococcus faecium; Female; Humans; Leukemia, Myeloid, Acute; Neutropenia; Staphylococcal Infections; Vancomycin Resistance; Virginiamycin | 2004 |
Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Drug Synergism; Humans; In Vitro Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Teicoplanin; Vancomycin; Virginiamycin | 2006 |
Mechanism of action of a novel recombinant peptide, MP1102, against Clostridium perfringens type C.
Topics: Ampicillin; Anti-Bacterial Agents; Cell Membrane; Chlortetracycline; Clostridium perfringens; DNA, Bacterial; Drug Synergism; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Nisin; Recombinant Proteins; Temperature; Vancomycin; Virginiamycin; Zinc | 2016 |